Efficacy of cetuximab and mutant selective EGFR inhibitor WZ4002 in EGFR T790M and non-T790M models of erlotinib resistant non-small cell lung cancer

被引：1
|
作者：
Tricker, Erin M. [1 ]
Xu, Chunxiao [1 ]
Wong, Kwok-Kin [1 ]
Janne, Pasi A. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2595
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Does T790M Disappear? Successful Gefitinib Rechallenge After T790M Disappearance in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer
    Hata, Akito
    Katakami, Nobuyuki
    Kaji, Reiko
    Fujita, Shiro
    Imai, Yukihiro
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : E27 - E29
  • [22] Role of T790M Mutation in EGFR-TKI Rechallenge for Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer
    Zhang, Qiu-Yi
    Ke, E-E
    Deng, Wei
    Niu, Fei-Yu
    Zhao, Ning
    Su, Jian
    Chen, Zhi-Hong
    Yang, Jin-Ji
    Xu, Chong-Rui
    Yan, Hong-Hong
    Wu, Yi-Long
    Zhou, Qing
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S271 - S271
  • [23] Non-invasive detection of EGFR T790M in gefitinib/erlotinib resistant NSCLC
    Kuang, Y.
    Rogers, A.
    Wang, L.
    Makrigiorgos, M.
    Vetrand, K.
    Thiede, S.
    Distel, R.
    Janne, P. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Treatment of EGFR T790M-Positive Non-Small Cell Lung Cancer
    Choo, Joan Rou-En
    Tan, Chee-Seng
    Soo, Ross A.
    TARGETED ONCOLOGY, 2018, 13 (02) : 141 - 156
  • [25] Phase I/II Study of AC0010, Mutant Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation
    Wu, Yi Long
    Zhou, Qing
    Liu, Xiaoqing
    Zhang, Li
    Zhou, Jianying
    Wu, Lin
    An, Tongtong
    Cheng, Ying
    Zheng, Xin
    Hu, Bei
    Jiang, Ji
    Fang, Xin
    Xu, Wanhong
    Xu, Xiao
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S437 - S438
  • [26] Treatment of EGFR T790M-Positive Non-Small Cell Lung Cancer
    Joan Rou-En Choo
    Chee-Seng Tan
    Ross A. Soo
    Targeted Oncology, 2018, 13 : 141 - 156
  • [27] EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Sakakibara, Rie
    Saiki, Masafumi
    Ariyasu, Ryo
    Koyama, Junji
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Ohyanagi, Fumiyoshi
    Ninomiya, Hironori
    Ishikawa, Yuichi
    Nishio, Makoto
    RESPIRATORY MEDICINE CASE REPORTS, 2018, 24 : 19 - 21
  • [28] Managing EGFR T790M Mutation in Advanced Non-Small Cell Lung Cancers in THAILAND
    Prempree, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2136 - S2136
  • [29] EGFR T790M resistance mutation in non small-cell lung carcinoma
    Denis, Marc G.
    Vallee, Audrey
    Theoleyre, Sandrine
    CLINICA CHIMICA ACTA, 2015, 444 : 81 - 85
  • [30] Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR
    Hwang, Ki-Eun
    Kwon, Su-Jin
    Kim, Young-Suk
    Park, Do-Sim
    Kim, Byoung-Ryun
    Yoon, Kwon-Ha
    Jeong, Eun-Taik
    Kim, Hak-Ryul
    EXPERIMENTAL CELL RESEARCH, 2014, 323 (02) : 288 - 296
12345